NCT05206604View on ClinicalTrials.gov

A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

February 9, 2022

Primary Completion Date

August 12, 2022

Study Completion Date

August 12, 2022

Conditions

Healthy

Interventions

DRUG

PF-07295324

Ointment

DRUG

PF-07259955

Cream

Trial Locations (1)

06511

New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT05206604 - A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955 | Biotech Hunter | Biotech Hunter